1887

Abstract

Ventilator-associated pneumonia (VAP) is a serious healthcare-associated infection that affects up to 30 % of intubated and mechanically ventilated patients in intensive care units (ICUs) worldwide. The bacterial aetiology and corresponding antimicrobial susceptibility of VAP is highly variable, and can differ between countries, national provinces and even between different wards in the same hospital. We aimed to understand and document changes in the causative agents of VAP and their antimicrobial susceptibility profiles retrospectively over an 11 year period in a major infectious disease hospital in southern Vietnam. Our analysis outlined a significant shift from to spp. as the most prevalent bacteria isolated from quantitative tracheal aspirates in patients with VAP in this setting. Antimicrobial resistance was common across all bacterial species and we found a marked proportional annual increase in carbapenem-resistant spp. over a 3 year period from 2008 (annual trend; odds ratio 1.656,  = 0.010). We further investigated the possible emergence of a carbapenem-resistant clone by multiple-locus variable number tandem repeat analysis, finding a -positive strain that was associated with an upsurge in the isolation of this pathogen. We additionally identified a single -positive isolate. This work highlights the emergence of a carbapenem-resistant clone of and a worrying trend of antimicrobial resistance in the ICU of the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.076646-0
2014-10-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/63/10/1386.html?itemId=/content/journal/jmm/10.1099/jmm.0.076646-0&mimeType=html&fmt=ahah

References

  1. Alp E., Voss A. 2006; Ventilator associated pneumonia and infection control. Ann Clin Microbiol Antimicrob 5:7 [View Article][PubMed]
    [Google Scholar]
  2. Aydemir H., Akduman D., Piskin N., Comert F., Horuz E., Terzi A., Kokturk F., Ornek T., Celebi G. 2013; Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia. Epidemiol Infect 141:1214–1222 [View Article][PubMed]
    [Google Scholar]
  3. Ayraud-Thévenot S., Huart C., Mimoz O., Taouqi M., Laland C., Bousseau A., Castel O. 2012; Control of multi-drug-resistant Acinetobacter baumannii outbreaks in an intensive care unit: feasibility and economic impact of rapid unit closure. J Hosp Infect 82:290–292 [View Article][PubMed]
    [Google Scholar]
  4. Balm M. N. D., Ngan G., Jureen R., Lin R. T. P., Teo J. W. P. 2013; OXA-181-producing Klebsiella pneumoniae establishing in Singapore. BMC Infect Dis 13:58 [View Article][PubMed]
    [Google Scholar]
  5. Bantar C., Famiglietti A., Radice M., Quinteros M.Antimicrobial CommitteeSIR Participants Group 2008; A 7-year national survey on bacterial resistance in bronchoalveolar lavage from patients hospitalized in Argentina. Diagn Microbiol Infect Dis 60:65–69 [View Article][PubMed]
    [Google Scholar]
  6. Chastre J., Blasi F., Masterton R. G., Rello J., Torres A., Welte T. 2014; European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Clin Microbiol Infect 20:Suppl 419–36 [View Article][PubMed]
    [Google Scholar]
  7. Chawla R. 2008; Epidemiology, etiology, and diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia in Asian countries. Am J Infect Control 36:SupplS93–S100 [View Article][PubMed]
    [Google Scholar]
  8. CLSI. 2012 Performance Standards for Antimicrobial Susceptibility Testing; 20th Informational Supplement M100-S20 Wayne, PA: Clinical and Laboratory Standards Institute;
  9. Davis K. A. 2006; Ventilator-associated pneumonia: a review. J Intensive Care Med 21:211–226 [View Article][PubMed]
    [Google Scholar]
  10. Gales A. C., Sader H. S., Jones R. N. 2002; Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997–2000). Diagn Microbiol Infect Dis 44:301–311 [View Article][PubMed]
    [Google Scholar]
  11. Gaynes R., Edwards J. R.National Nosocomial Infections Surveillance System 2005; Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41:848–854 [View Article][PubMed]
    [Google Scholar]
  12. Hoang T. H., Wertheim H., Minh N. B., Duong T. N., Anh D. D., Phuong T. T. L., Son T. H., Izumiya H., Ohnishi M.& other authors ( 2013; Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains containing New Delhi metallo-beta-lactamase isolated from two patients in Vietnam. J Clin Microbiol 51:373–374 [View Article][PubMed]
    [Google Scholar]
  13. Holt K. E., Thieu Nga T. V., Thanh D. P., Vinh H., Kim D. W., Vu Tra M. P., Campbell J. I., Hoang N. V. M., Vinh N. T.& other authors ( 2013; Tracking the establishment of local endemic populations of an emergent enteric pathogen. Proc Natl Acad Sci U S A 110:17522–17527 [View Article][PubMed]
    [Google Scholar]
  14. Hu L., Zhong Q., Tu J., Xu Y., Qin Z., Parsons C., Zhang B., Hu X., Wang L.& other authors ( 2013; Emergence of blaNDM-1 among Klebsiella pneumoniae ST15 and novel ST1031 clinical isolates in China. Diagn Microbiol Infect Dis 75:373–376 [View Article][PubMed]
    [Google Scholar]
  15. Isozumi R., Yoshimatsu K., Yamashiro T., Hasebe F., Nguyen B. M., Ngo T. C., Yasuda S. P., Koma T., Shimizu K., Arikawa J. 2012; blaNDM-1-positive Klebsiella pneumoniae from environment, Vietnam. Emerg Infect Dis 18:1383–1385 [View Article][PubMed]
    [Google Scholar]
  16. Jean S.-S., Hsueh P.-R. 2011; Current review of antimicrobial treatment of nosocomial pneumonia caused by multidrug-resistant pathogens. Expert Opin Pharmacother 12:2145–2148 [View Article][PubMed]
    [Google Scholar]
  17. Joseph N. M., Sistla S., Dutta T. K., Badhe A. S., Parija S. C. 2010; Ventilator-associated pneumonia: a review. Eur J Intern Med 21:360–368 [View Article][PubMed]
    [Google Scholar]
  18. Koenig S. M., Truwit J. D. 2006; Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev 19:637–657 [View Article][PubMed]
    [Google Scholar]
  19. Lagamayo E. N. 2008; Antimicrobial resistance in major pathogens of hospital-acquired pneumonia in Asian countries. Am J Infect Control 36:SupplS101–S108 [View Article][PubMed]
    [Google Scholar]
  20. Lee M. S., Walker V., Chen L. F., Sexton D. J., Anderson D. J. 2013; The epidemiology of ventilator-associated pneumonia in a network of community hospitals: a prospective multicenter study. Infect Control Hosp Epidemiol 34:657–662 [View Article][PubMed]
    [Google Scholar]
  21. Melsen W. G., Rovers M. M., Bonten M. J. M. 2009; Ventilator-associated pneumonia and mortality: a systematic review of observational studies. Crit Care Med 37:2709–2718 [View Article][PubMed]
    [Google Scholar]
  22. Mendes R. E., Bell J. M., Turnidge J. D., Castanheira M., Jones R. N. 2009; Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia–Pacific nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother 63:55–59 [View Article][PubMed]
    [Google Scholar]
  23. Morrow B. M., Argent A. C., Jeena P. M., Green R. J. 2009; Guideline for the diagnosis, prevention and treatment of paediatric ventilator-associated pneumonia. S Afr Med J 99:255–267[PubMed]
    [Google Scholar]
  24. NNIS System 2004; National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32:470–485 [View Article][PubMed]
    [Google Scholar]
  25. Nga T. V. T., Parry C. M., Le T., Lan N. P. H., Diep T. S., Campbell J. I., Hoang N. V. M., Dung T., Wain J.& other authors ( 2012; The decline of typhoid and the rise of non-typhoid salmonellae and fungal infections in a changing HIV landscape: bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 106:26–34 [View Article][PubMed]
    [Google Scholar]
  26. Nordmann P., Poirel L., Carrër A., Toleman M. A., Walsh T. R. 2011; How to detect NDM-1 producers. J Clin Microbiol 49:718–721 [View Article][PubMed]
    [Google Scholar]
  27. Pourcel C., Minandri F., Hauck Y., D’Arezzo S., Imperi F., Vergnaud G., Visca P. 2011; Identification of variable-number tandem-repeat (VNTR) sequences in Acinetobacter baumannii and interlaboratory validation of an optimized multiple-locus VNTR analysis typing scheme. J Clin Microbiol 49:539–548 [View Article][PubMed]
    [Google Scholar]
  28. Rolain J.-M., Diene S. M., Kempf M., Gimenez G., Robert C., Raoult D. 2013; Real-time sequencing to decipher the molecular mechanism of resistance of a clinical pan-drug-resistant Acinetobacter baumannii isolate from Marseille, France. Antimicrob Agents Chemother 57:592–596 [View Article][PubMed]
    [Google Scholar]
  29. Rosenthal V. D., Udwadia F. E., Muñoz H. J., Erben N., Higuera F., Abidi K., Medeiros E. A., Fernández Maldonado E., Kanj S. S.& other authors ( 2011; Time-dependent analysis of extra length of stay and mortality due to ventilator-associated pneumonia in intensive-care units of ten limited-resources countries: findings of the International Nosocomial Infection Control Consortium (INICC). Epidemiol Infect 139:1757–1763 [View Article][PubMed]
    [Google Scholar]
  30. Snitkin E. S., Zelazny A. M., Gupta J., Palmore T. N., Murray P. R., Segre J. A.NISC Comparative Sequencing Program 2013; Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment. Genome Res 23:1155–1162 [View Article][PubMed]
    [Google Scholar]
  31. Tadros M., Williams V., Coleman B. L., McGeer A. J., Haider S., Lee C., Iacovides H., Rubinstein E., John M.& other authors ( 2013; Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals. PLoS ONE 8:e75171 [View Article][PubMed]
    [Google Scholar]
  32. van Nieuwenhoven C. A., Buskens E., Bergmans D. C., van Tiel F. H., Ramsay G., Bonten M. J. M. 2004; Oral decontamination is cost-saving in the prevention of ventilator-associated pneumonia in intensive care units. Crit Care Med 32:126–130 [View Article][PubMed]
    [Google Scholar]
  33. Vien T. M., Minh N. N. Q., Thuong T. C., Khuong H. D., Nga T. V. T., Thompson C., Campbell J. I., de Jong M., Farrar J. J.& other authors ( 2012; The co-selection of fluoroquinolone resistance genes in the gut flora of Vietnamese children. PLoS ONE 7:e42919 [View Article][PubMed]
    [Google Scholar]
  34. Vinh H., Nhu N. T. K., Nga T. V. T., Duy P. T., Campbell J. I., Hoang N. V. M., Boni M. F., My P. V. T., Parry C.& other authors ( 2009; A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation. BMC Infect Dis 9:204 [View Article][PubMed]
    [Google Scholar]
  35. Warren D. K., Shukla S. J., Olsen M. A., Kollef M. H., Hollenbeak C. S., Cox M. J., Cohen M. M., Fraser V. J. 2003; Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 31:1312–1317 [View Article][PubMed]
    [Google Scholar]
  36. Woodford N., Ellington M. J., Coelho J. M., Turton J. F., Ward M. E., Brown S., Amyes S. G. B., Livermore D. M. 2006; Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27:351–353 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.076646-0
Loading
/content/journal/jmm/10.1099/jmm.0.076646-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error